Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.
April 06, 2022
Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (…
Read More
Brigitta Brott, M.D., and Ho-Wook Jun, Ph.D.
April 06, 2022
NIH Grant to UAB will Fund Study of Safer, More Durable Stents
April 6, 2022 – Narrowed arteries can restrict blood flow to the heart. One treatment is inserting a stent — a small…
Read More
According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.
April 06, 2022
Dixon GRE Technique Outperforms Clinical Standard for Unenhanced Coronary MRA
April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE)…
Read More
Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease.
April 06, 2022
AI Enables Personalized Treatment of Myocarditis
April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19…
Read More
Kartik Balachandran
April 06, 2022
NIH Awards $437,000 to Study Effects of COVID on Aortic Valve
April 6, 2022 – The National Institute of Health awarded $436,642 to associate professor of biomedical engineering,…
Read More
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.
April 05, 2022
Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System
April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber…
Read More
GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device outside of the hospital setting – at home or on the go – directly into GE Healthcare’s MUSE Cardiac Management System for physicians to view and evaluate.
April 04, 2022
GE Healthcare and AliveCor Integrate Data from ECGs Into Clinical Workflow
April 4, 2022 – GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead…
Read More
The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on May 13, 2022 will feature an opening session that includes Geoffrey Ginsburg, MD, PhD and Joshua C. Denny, MD, MS.
April 04, 2022
ACC Course Provides Updates from NIH's All of Us Research Program
April 4, 2022 – The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on…
Read More
A stroke patient performing upper limb robotic therapy
April 04, 2022
Researchers Examine Impact of Robotic Assistance Level in the Upper Limb Rehabilitation of Stroke Survivors
April 4, 2022 – Researches at the Department of Occupational Therapy, College of Health and Human Sciences, Osaka…
Read More
Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core team of clinicians specializing in primary care, pulmonology and physical therapy.
April 04, 2022
Keck Medicine of USC Launches COVID Recovery Clinic to Treat Patients with Long COVID-19
April 4, 2022 – Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core…
Read More
Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to researchers at the National Institutes of Health.
April 04, 2022
Good Hydration May Reduce Long-term Risks for Heart Failure
April 4, 2022 – Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to…
Read More
Observational research has suggested that light alcohol consumption may provide heart-related health benefits, but in a large study published in JAMA Network Open, alcohol intake at all levels was linked with higher risks of cardiovascular disease.
April 04, 2022
Large Study Challenges Theory that Light Alcohol Consumption Benefits Heart Health
April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health…
Read More
But scientists at the Medical College of Georgia and Georgia State University also say that the chronic high-salt diet most Americans consume can turn this system against us, resulting in hyperactivity of these neurons, continuing production of this hormone vasopressin, constriction of blood vessels and increasing our risk for common cardiometabolic diseases like high blood pressure and heart disease.
April 04, 2022
New Clues About How A High-Salt Diet Contributes to Cardiometabolic Diseases Found Deep in the Brain
April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more…
Read More
Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled AIM HIGHer IDE clinical study (Assessment of Implantable CCM in the Heart Failure Group with Higher Ejection Fraction) evaluating CCM therapy for patients who have left ventricular ejection fraction ranging between 40% and 60% inclusive. The study will be conducted across approximately 150 cente
April 04, 2022
Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer Study
April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart…
Read More
Nexletol logo
April 04, 2022
Esperion Announces Two NEXLETOL Data Presentations at ACC.22
April 4, 2022 –  Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL…
Read More
Significant VHD is commonly encountered in practice, more commonly with advancing age, among women, and identified more frequently in centers offering percutaneous mitral therapies.
April 03, 2022
egnite, Inc. Announces Data from the Largest Contemporary Analysis of Valvular Heart Disease Prevalence in the US
April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial…
Read More
A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.
April 03, 2022
ACC22: Interim Findings Show Promise in Decreasing Shortness of Breath From Hypertrophic Cardiomyopathy
April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of…
Read More
Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today presented detailed results from its phase 1 APOLLO trial
April 03, 2022
Silence Therapeutics Announces Detailed Results from SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at ACC22
April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering…
Read More
Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams.
April 02, 2022
Aidoc Expands AI Service to X-ray, Receiving FDA 510(k) Clearance for Pneumothorax
April 2, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance…
Read More
Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace [OLK1] at the American College of Cardiology’s Annual Scientific Session & Expo (ACC 2022).
April 02, 2022
Philips Launches Ultrasound Workspace at ACC 2022
April 2, 2022 —  Royal Philips, a global leader in health technology, today announced the launch of Ultrasound…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now